All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Strive Pharmacy

503A Outsourcing Facility — FDA safety data from public records

By FormBlends Editorial Team·

On This Page

FDA Registered503A Outsourcing Facility503B Facility

Connecticut-based 503B outsourcing facility specializing in sterile compounding across GLP-1 medications, hormone therapy, and other specialty products.

Website: strivepharmacy.com

Data last verified: 2026-04-25

Company Snapshot

Entity Type

503A Outsourcing Facility

FDA Registration

active

Warning Letters

0

Recalls

0

States Licensed

Not listed

Compounding Status

503B

What This Company Profile Actually Tells You

Strive Pharmacy is categorized here as a 503B outsourcing facility or closely related sterile compounding operation. That matters because 503B facilities occupy a different regulatory lane than telehealth brands: they are physical drug establishments with FDA-facing registration obligations and manufacturing-style oversight expectations.

Strive Pharmacy's exact geographic footprint is not summarized on this page, so readers should confirm state availability before assuming access in their market. Readers evaluating a 503B facility should care about sterility controls, batch processes, inspection history, recalls, and whether the facility role being marketed to the public matches the legal operating status reflected in FDA records.

From a search and trust perspective, these pages need to answer a more technical question than a typical company review. Users are not just deciding whether they like the brand. They are trying to understand whether the facility is properly registered, how it is classified, and what public safety signals exist around its operations.

Strive Pharmacy Background

Market Position

Strive is a backend facility-level name within the broader compounding ecosystem and tends to matter most when patients investigate who is actually fulfilling medication orders.

Business Model

As a 503B outsourcing facility, Strive should be read as part of the production and fulfillment layer, not the telehealth acquisition layer.

Pharmacy And Supply Notes

If Strive is identified as the source facility, patients should use that information to ask more detailed questions about batch quality, shipping, and the relationship between the telehealth seller and the facility.

Consumer Risk Notes

Facilities can look interchangeable to consumers, but they are not. Clear provider disclosure about why Strive is being used and how quality is monitored matters.

Key Facts

Strive is relevant as a facility partner rather than a consumer-facing telehealth brand.

Its active registration status provides a useful verification checkpoint.

Patients should still ask how Strive fits into the full prescribing and fulfillment chain.

Risk Summary

No FDA warning letters are currently shown in this profile.

No recall events are currently shown in the FDA enforcement data surfaced here.

FDA registration status is shown as active.

Compounding status is listed as 503B.

Regulatory And Compliance Analysis

Registration Context

Strive Pharmacy shows an active FDA registration record in the establishment database. That is a useful signal for facility verification, but it should still be read as registration data rather than a product approval or quality guarantee.

Warning Letter Readout

We did not find FDA warning letters for Strive Pharmacy in this profile. That is better than the alternative, but it is not a blanket endorsement. A clean warning-letter record only tells you that this page is not currently surfacing a published FDA warning letter tied to the entity.

Recall Readout

No recall events are shown for Strive Pharmacy here. For consumers, that lowers one category of concern, but it still does not replace verification of sourcing, labeling, temperature handling, and pharmacy quality controls.

Adverse Event Context

This profile does not currently show a meaningful adverse-event dataset for Strive Pharmacy. In practice, that usually means readers should lean more heavily on registration, recalls, warning letters, and pharmacy-partner transparency when evaluating risk.

FDA Registration

Status
FDA Registered
FEI Number
3016773421
Facility Type
503B Outsourcing Facility
Last Verified
2026-04-10

Source: FDA Drug Establishment Registration & Listing

FDA Warning Letters (0)

No FDA warning letters are currently shown for Strive Pharmacy in this profile. That is helpful context, but users should still verify current marketing claims, pharmacy sourcing, and how the company describes compounded medications.

Recall History (0)

No recalls are currently displayed for Strive Pharmacy in the openFDA enforcement data surfaced on this page. That lowers one obvious risk signal, but it should not be treated as proof that all products, batches, or fulfillment practices are problem-free.

Source: openFDA Drug Enforcement API

Adverse Event Reports

This profile does not currently show a meaningful adverse-event summary for Strive Pharmacy. When that dataset is absent, readers should lean more on the documented public record around registration, recalls, warning letters, and pharmacy-partner transparency.

Source: FDA Adverse Event Reporting System (FAERS). Adverse event reports do not establish causation.

Questions Patients Should Ask Before Using Strive Pharmacy

Can Strive Pharmacy confirm the exact facility name, operating status, and whether the prescription will be filled under a 503A or 503B framework?

What does Strive Pharmacy tell patients about compounded versus FDA-approved products, and does that language avoid implying equivalence or approval where it does not exist?

How does Strive Pharmacy handle dose escalations, refill delays, refunds, cancellations, and temperature-sensitive shipping problems?

If a patient has a side effect or receives a product-quality concern, what is the human escalation path and how quickly does Strive Pharmacy respond?

Can Strive Pharmacy provide lot-level documentation, pharmacy details, and a clear explanation of what safety checks happen before medication is dispensed?

Similar Companies

These related profiles are useful for searchers comparing Strive Pharmacy against adjacent providers or pharmacies. Reading similar pages side by side usually reveals whether a concern is unique to one company or common across this category.

How To Use This Profile

This profile organizes public-source safety signals for Strive Pharmacy, including FDA registration status, warning letters, recalls, and any adverse event summary data available in the dataset.

A company can appear relatively clean here and still deserve more diligence, because absence of a warning letter or recall is not the same as proof of quality.

For 503a outsourcing facility pages especially, readers should distinguish between the consumer-facing brand and the pharmacy or facility that actually handles medication production or dispensing.

Primary Sources And Verification Links

Use these links to validate the key claims in this profile and to separate the consumer-facing brand story from the underlying regulatory record.

Strive Pharmacy official website

Primary facility website used to verify identity and personalized-compounding positioning.

Open source

Strive 503B expansion announcement

Supports the 503B outsourcing-facility framing reflected in this profile.

Open source

Strive locations page

Supports the multi-location operational visibility described in this profile.

Open source

Looking for a Verified GLP-1 Provider?

FormBlends partners with licensed 503A compounding pharmacies. Every compound is third-party tested with certificates of analysis.

Learn More

Disclaimer: This page aggregates publicly available data from the FDA, state pharmacy boards, and other government sources. It is provided for informational purposes only and does not constitute medical or legal advice. FDA registration does not imply FDA approval or endorsement. The absence of warning letters or recalls does not guarantee safety or quality. Always consult your healthcare provider before making decisions about medications. Data may not reflect the most current status. Last updated: 2026-04-25.

Safety Guides

GLP-1 Safety Alerts

Get notified when the FDA issues warning letters, recalls, or regulatory updates affecting GLP-1 medications and compounding pharmacies.

Free. No spam. Unsubscribe anytime.

Frequently Asked Questions

Is Strive Pharmacy FDA registered?

Strive Pharmacy is currently registered with the FDA. Registration status was last verified on 2026-04-10. Note that FDA registration does not imply FDA approval or endorsement.

Has Strive Pharmacy received any FDA warning letters?

We have not found any FDA warning letters issued to Strive Pharmacy in our records. This page is updated regularly as new FDA data becomes available.

Does Strive Pharmacy have any recalls?

We have not found any recalls associated with Strive Pharmacy in the openFDA enforcement database.

Is Strive Pharmacy a telehealth company or a pharmacy?

Strive Pharmacy is categorized in this profile as a 503a outsourcing facility. That distinction matters because a telehealth brand, a 503A pharmacy, and a 503B outsourcing facility operate under different regulatory expectations.

Does a clean profile mean Strive Pharmacy is definitely safe?

No. A clean profile means we are not currently surfacing certain FDA signals like warning letters or recalls for Strive Pharmacy. It does not guarantee product quality, customer-service quality, or future regulatory compliance.

What should patients verify before using Strive Pharmacy?

Patients should verify who is prescribing, which pharmacy or outsourcing facility is actually fulfilling the medication, what the company says about compounded versus FDA-approved products, and how billing, cancellations, and side-effect escalation are handled.